Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
PharmaPendium serves as a robust platform that grants users access to a wide array of FDA and EMA drug approval documents, encompassing essential aspects like pharmacokinetics, pharmacodynamics, and safety evaluations. This resource delivers in-depth insights into drug-drug interactions, side effects, and outcomes from clinical studies, thereby empowering stakeholders to make well-informed decisions during the drug development process and when making regulatory submissions. Its rich database aids researchers and healthcare practitioners in assessing both the efficacy and safety of medications, playing a pivotal role in the progression of pharmaceutical research and enhancing patient care. Users can explore historical regulatory submissions and leverage past precedents to better understand and anticipate agency requirements. The interface allows for a seamless transition from tabular data to dynamic charts, graphs, and other visual tools, making it easier to analyze and interpret findings. Additionally, users can search for information related to adverse events (MedDRA), therapeutic targets, drug indications, and endpoints utilizing standardized data. Result pages effectively connect preclinical research with clinical applications, facilitating a comprehensive understanding of the drug development landscape. Overall, this platform not only streamlines the research process but also fosters collaboration and knowledge-sharing among industry professionals.
Description
Preventive medicine represents the next frontier in healthcare. Our mission is to assist healthcare providers in identifying and addressing high-risk patients effectively, thereby ensuring patient safety. This proactive approach aims to reduce the incidence of Adverse Drug Reactions (ADRs) within healthcare facilities, where studies show that 5%-10% of hospitalized patients experience ADRs, leading to increased risks, prolonged hospital stays, and financial losses due to denied reimbursements for extra days and procedures. Notably, these adverse events are avoidable. We collaborate with Accountable Care Organizations (ACOs), Health Maintenance Organizations (HMOs), and payers to minimize unnecessary emergency room visits and hospitalizations, particularly focusing on the elderly population, as data indicate that 15%-30% of ER visits for patients aged 65 and older are attributed to ADRs, frequently resulting in hospital admissions. These preventable occurrences highlight the importance of our work. Our approach is founded on advanced scientific principles that integrate multidisciplinary research. Our technology leverages cutting-edge medical research alongside innovative data science, creating a robust platform that leads to improved patient outcomes and enhances overall healthcare efficiency.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Elsevier
Founded
1880
Country
Netherlands
Website
www.elsevier.com/products/pharmapendium
Vendor Details
Company Name
mydimed
Country
Israel
Website
www.mydimed.com
Product Features
Product Features
Predictive Analytics
AI / Machine Learning
No
Benchmarking
No
Data Blending
No
Data Mining
No
Demand Forecasting
No
For Education
No
For Healthcare
No
Modeling & Simulation
No
Sentiment Analysis
No